52186-76-2 Usage
Uses
Used in Pharmaceutical Industry:
CYCLOPROPANECARBOXIMIDIC ACID ETHYL ESTER is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the formation of complex organic molecules that can be used in drug development.
Used in Agrochemical Industry:
In the agrochemical sector, CYCLOPROPANECARBOXIMIDIC ACID ETHYL ESTER is used as a precursor in the production of agrochemicals, playing a crucial role in the synthesis of compounds that help protect crops from pests and diseases.
Used in Organic Synthesis:
CYCLOPROPANECARBOXIMIDIC ACID ETHYL ESTER is utilized as a versatile building block in organic synthesis for its capacity to react with other compounds to form a wide array of organic products, contributing to the diversity of chemical research and development.
Safety Precautions:
It is important to handle and store CYCLOPROPANECARBOXIMIDIC ACID ETHYL ESTER with care due to its flammable nature and potential to cause skin and eye irritation upon contact. Proper safety measures should be implemented to mitigate these risks.
Check Digit Verification of cas no
The CAS Registry Mumber 52186-76-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,1,8 and 6 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 52186-76:
(7*5)+(6*2)+(5*1)+(4*8)+(3*6)+(2*7)+(1*6)=122
122 % 10 = 2
So 52186-76-2 is a valid CAS Registry Number.
InChI:InChI=1/C6H11NO/c1-2-8-6(7)5-3-4-5/h5,7H,2-4H2,1H3
52186-76-2Relevant academic research and scientific papers
An efficient, stereocontrolled and versatile synthetic route to bicyclic partially saturated privileged scaffolds
Bond, Andrew D.,Hanby, Abigail R.,King, Thomas A.,Moss, Thomas A.,Sore, Hannah F.,Spring, David R.,Stewart, Hannah L.
supporting information, p. 6818 - 6821 (2020/07/04)
Herein, we describe the development of a simple, high yielding and stereocontrolled strategy for the synthesis of a series of triazolopiperazines and other biologically relevant fused scaffolds from optically active amino acids. This route was applied to the synthesis of 22 scaffolds containing new, previously inaccessible vectors and used to access a novel analogue of ganaplacide.
PYRIDINE DERIVATIVE AS ASK1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF
-
Paragraph 0115-0117, (2019/12/05)
Disclosed in the present invention are a compound as shown in formula (II), a tautomer or a pharmaceutically acceptable salt thereof, and also disclosed is the use thereof in preparing a drug for treating an ASK1-associated disease.
